Therefore, Sarcorucinine-D could be considered a potential lead molecule for Alzheimer’s disease based on its properties as a noncompetitive AChE inhibitor and a Ca2+ channel blocker. Here, ACHE is linked to early-onset autosomal dominant Alzheimer disease.